Katze lab signs contract with Revalesio to study novel approaches to viral diseases

Date: September 14, 2011

Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the University of Washington to bring hope to sufferers of influenza, HIV and hepatitis C.

Read More…